Literature DB >> 21762300

Moving towards the New International Study Group for Pancreatic Surgery (ISGPS) definitions in pancreaticoduodenectomy: a comparison between the old and new.

Winson Jianhong Tan1, Alfred Wei Chieh Kow, Kui Hin Liau.   

Abstract

BACKGROUND: The International Study Group for Pancreatic Surgery (ISGPS) has proposed several definitions for postoperative pancreatic fistula (POPF), delayed gastric emptying (DGE) and post-pancreatectomy haemorrhage (PPH). We assessed the effects of implementing these definitions on predicting outcomes.
METHODS: A database of 77 patients who underwent pancreaticoduodenectomy between January 2005 and December 2009 was analysed. Morbidities were defined and classified using the ISGPS definitions and recalculated based on the definitions adopted by our institution ('Old' definitions) prior to the implementation of ISGPS definitions. Data for the two groups were then compared.
RESULTS: The morbidity rate rose to 70.1% from 27.2% when ISGPS rather than Old definitions were used to define morbidities (P < 0.001). Incidences of DGE, POPF and PPH were 20.7%, 39.0% and 10.4%, respectively. Rates of DGE and POPF were significantly higher according to ISGPS definitions than to Old definitions (20.7% vs. 5.2% [P= 0.001] and 39.0% vs. 15.6% [P= 0.004], respectively). According to the ISGPS definitions, all of the 12 additional patients with DGE and 12 of the 18 additional patients with POPF had grade A morbidities. Patients with ISGPS-defined morbidity had a longer intensive care unit (ICU) stay, longer postoperative stay and longer total stay (P= 0.030, P= 0.007 and P= 0.001, respectively).
CONCLUSIONS: The morbidity rate more than doubled when ISGPS definitions were applied (an additional 42.9% of patients demonstrated morbidities). The majority of patients with DGE and POPF had grade A morbidities. The ISGPS definitions correlate well with ICU stay, postoperative stay and total length of stay.
© 2011 International Hepato-Pancreato-Biliary Association.

Entities:  

Mesh:

Year:  2011        PMID: 21762300      PMCID: PMC3163279          DOI: 10.1111/j.1477-2574.2011.00336.x

Source DB:  PubMed          Journal:  HPB (Oxford)        ISSN: 1365-182X            Impact factor:   3.647


  47 in total

Review 1.  Pancreaticoduodenectomy.

Authors:  Andrew L Warshaw; Sarah P Thayer
Journal:  J Gastrointest Surg       Date:  2004 Sep-Oct       Impact factor: 3.452

2.  Factors influencing survival after pancreaticoduodenectomy for pancreatic cancer.

Authors:  J L Cameron; D W Crist; J V Sitzmann; R H Hruban; J K Boitnott; A J Seidler; J Coleman
Journal:  Am J Surg       Date:  1991-01       Impact factor: 2.565

3.  Ten-year experience with 733 pancreatic resections: changing indications, older patients, and decreasing length of hospitalization.

Authors:  J H Balcom; D W Rattner; A L Warshaw; Y Chang; C Fernandez-del Castillo
Journal:  Arch Surg       Date:  2001-04

Review 4.  Complications of pancreatic cancer resection.

Authors:  C M Halloran; P Ghaneh; L Bosonnet; M N Hartley; R Sutton; J P Neoptolemos
Journal:  Dig Surg       Date:  2002       Impact factor: 2.588

5.  Changes in morbidity after pancreatic resection: toward the end of completion pancreatectomy.

Authors:  Markus W Büchler; Markus Wagner; Bruno M Schmied; Waldemar Uhl; Helmut Friess; Kaspar Z'graggen
Journal:  Arch Surg       Date:  2003-12

6.  The complications of pancreatectomy.

Authors:  M Trede; G Schwall
Journal:  Ann Surg       Date:  1988-01       Impact factor: 12.969

7.  Temporary fibrin glue occlusion of the main pancreatic duct in the prevention of intra-abdominal complications after pancreatic resection: prospective randomized trial.

Authors:  Bertrand Suc; Simon Msika; Abe Fingerhut; Gilles Fourtanier; Jean-Marie Hay; Franck Holmières; Bernard Sastre; Pierre-Louis Fagniez
Journal:  Ann Surg       Date:  2003-01       Impact factor: 12.969

8.  An analysis of risk factors for pancreatic fistula after pancreaticoduodenectomy: clinical impact of bile juice infection on day 1.

Authors:  Takahiro Kajiwara; Yoshihiro Sakamoto; Noriaki Morofuji; Satoshi Nara; Minoru Esaki; Kazuaki Shimada; Tomoo Kosuge
Journal:  Langenbecks Arch Surg       Date:  2009-08-05       Impact factor: 3.445

9.  Reconsideration of postoperative oral intake tolerance after pancreaticoduodenectomy: prospective consecutive analysis of delayed gastric emptying according to the ISGPS definition and the amount of dietary intake.

Authors:  Emi Akizuki; Yasutoshi Kimura; Takayuki Nobuoka; Masafumi Imamura; Minoru Nagayama; Tomoko Sonoda; Koichi Hirata
Journal:  Ann Surg       Date:  2009-06       Impact factor: 12.969

10.  Pancreaticoduodenectomy with or without distal gastrectomy and extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma, part 2: randomized controlled trial evaluating survival, morbidity, and mortality.

Authors:  Charles J Yeo; John L Cameron; Keith D Lillemoe; Taylor A Sohn; Kurtis A Campbell; Patricia K Sauter; JoAnn Coleman; Ross A Abrams; Ralph H Hruban
Journal:  Ann Surg       Date:  2002-09       Impact factor: 12.969

View more
  15 in total

1.  Postpancreatectomy hemorrhage (PPH): predictors and management from a prospective database.

Authors:  B Darnis; R Lebeau; X Chopin-Laly; M Adham
Journal:  Langenbecks Arch Surg       Date:  2013-02-26       Impact factor: 3.445

2.  Peri-operative risk factors for delayed gastric emptying after a pancreaticoduodenectomy.

Authors:  Jamie R Robinson; Paula Marincola; Julia Shelton; Nipun B Merchant; Kamran Idrees; Alexander A Parikh
Journal:  HPB (Oxford)       Date:  2015-02-28       Impact factor: 3.647

3.  Significance of preoperative radiographic pancreatic density in predicting pancreatic fistula after surgery for pancreatic neuroendocrine tumors.

Authors:  Yasmine Assadipour; Saïd C Azoury; Nicholas N Schaub; Young Hong; Robert Eil; Suzanne M Inchauste; Seth M Steinberg; Aradhana M Venkatesan; Steven K Libutti; Marybeth S Hughes
Journal:  Am J Surg       Date:  2015-12-12       Impact factor: 2.565

Review 4.  Reconstruction after pancreatoduodenectomy: Pancreatojejunostomy vs pancreatogastrostomy.

Authors:  Tatiana Gómez; Ana Palomares; Mario Serradilla; Luis Tejedor
Journal:  World J Gastrointest Oncol       Date:  2014-09-15

Review 5.  Improving outcomes in pancreatic cancer: key points in perioperative management.

Authors:  José M Alamo; Luis M Marín; Gonzalo Suarez; Carmen Bernal; Juan Serrano; Lydia Barrera; Miguel A Gómez; Jordi Muntané; Francisco J Padillo
Journal:  World J Gastroenterol       Date:  2014-10-21       Impact factor: 5.742

6.  Rate of clinically significant postoperative pancreatic fistula in pancreatic neuroendocrine tumors.

Authors:  Suzanne M Inchauste; Brock J Lanier; Steven K Libutti; Giao Q Phan; Naris Nilubol; Seth M Steinberg; Electron Kebebew; Marybeth S Hughes
Journal:  World J Surg       Date:  2012-07       Impact factor: 3.352

7.  Hemorrhage after pancreaticoduodenectomy: does timing matter?

Authors:  Gyulnara G Kasumova; Mariam F Eskander; Tara S Kent; Sing Chau Ng; A James Moser; Muneeb Ahmed; Douglas K Pleskow; Mark P Callery; Jennifer F Tseng
Journal:  HPB (Oxford)       Date:  2016-08-11       Impact factor: 3.647

8.  Improved survival after palliative resection of unsuspected stage IV pancreatic ductal adenocarcinoma.

Authors:  Younghwan Kim; Song Cheol Kim; Ki Byoung Song; Jayoun Kim; Dae Ryong Kang; Jae Hoon Lee; Kwang-Min Park; Young-Joo Lee
Journal:  HPB (Oxford)       Date:  2016-02-08       Impact factor: 3.647

9.  Early enteral nutrition vs parenteral nutrition following pancreaticoduodenectomy: Experience from a single center.

Authors:  Jian-Wen Lu; Chang Liu; Zhao-Qing Du; Xue-Min Liu; Yi Lv; Xu-Feng Zhang
Journal:  World J Gastroenterol       Date:  2016-04-14       Impact factor: 5.742

10.  Efficacy and complications of nasojejunal, jejunostomy and parenteral feeding after pancreaticoduodenectomy.

Authors:  Arja Gerritsen; Marc G Besselink; Kasia P Cieslak; Menno R Vriens; Elles Steenhagen; Richard van Hillegersberg; Inne H Borel Rinkes; I Quintus Molenaar
Journal:  J Gastrointest Surg       Date:  2012-04-20       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.